Emily Anthes is a freelance science journalist and author based in Brooklyn, New York. She writes news stories for The Transmitter. Her work has also appeared in The New York Times, Wired, Nature and elsewhere. Her book, “Frankenstein’s Cat: Cuddling Up to Biotech’s Brave New Beasts,” was published in March 2013. She has a master’s degree in science writing from the Massachusetts Institute of Technology and a bachelor’s degree in the history of science and medicine from Yale.
Emily Anthes
Contributing Writer
Spectrum
From this contributor
Extra proteins alter microglia and behavior in mice
The overproduction of proteins in brain cells called microglia causes social impairments, cognitive deficits and repetitive behavior in male mice, a new study has found.
Extra proteins alter microglia and behavior in mice
By
Emily Anthes
29 May 2020 | 4 min read
Popular autism screening tool is unreliable, study suggests
A short, widely used screening survey for autism called the AQ-10 may not be reliable for measuring traits of the condition in the general population.
Popular autism screening tool is unreliable, study suggests
By
Emily Anthes
2 April 2020 | 3 min read
Little-known gene tied to autism, developmental delay
Rare mutations in a gene called BAZ2B are associated with various conditions of brain development, including autism.
Little-known gene tied to autism, developmental delay
By
Emily Anthes
28 February 2020 | 4 min read
Sponsors of clinical trials may report data late or never
Many clinical trials, including those related to autism, do not report their results within a year of their completion.
Sponsors of clinical trials may report data late or never
By
Emily Anthes
10 February 2020 | 5 min read
Autism-linked gene variants increase odds of attention deficit
A collection of rare genetic variants associated with autism and schizophrenia also seem to increase a person's odds of having attention deficit hyperactivity disorder.
Autism-linked gene variants increase odds of attention deficit
By
Emily Anthes
18 November 2019 | 4 min read
Explore more from The Transmitter
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
By
Brendan Borrell
1 October 2025 | 11 min read
Why we need basic science to better understand the neurobiology of psychedelics
Despite the many psychedelics clinical trials underway, there is still much we don’t know about how these drugs work. Preclinical studies represent our best viable avenue to answer these lingering questions.
Why we need basic science to better understand the neurobiology of psychedelics
Despite the many psychedelics clinical trials underway, there is still much we don’t know about how these drugs work. Preclinical studies represent our best viable avenue to answer these lingering questions.
By
Devin Effinger, Melissa Herman
1 October 2025 | 7 min listen
Facial movements telegraph cognition in mice
If you give a mouse a decision, its thought process may show on its face.
Facial movements telegraph cognition in mice
If you give a mouse a decision, its thought process may show on its face.
By
Lauren Schneider
30 September 2025 | 0 min watch